After reporting a loss this time last year, Cytosorbents (Monmouth Junction, N.J.) reported second-quarter net income of $1.4 million, beating Wall Street expectations. The company, which develops blood purification technology, said it had a 5-cent profit on a per-share basis in the quarter. Analysts surveyed by Zacks Investment Research estimated a 9-cent loss for the company on a per-share basis. Read More
